Drug intelligence / Profile preview

(S)-ACE-OH

Development stage
Preclinical
Lead developer
National Institute of Biological Sciences
Modality
Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules
01

Overview

(S)-ACE-OH is a small molecule metabolite of the phenothiazine sedative acepromazine that functions as a molecular glue to facilitate targeted protein degradation (TPD). It specifically recruits the E3 ubiquitin ligase TRIM21 to the multimeric Nuclear Pore Complex (NPC) protein NUP98. This recruitment triggers the selective ubiquitination and proteasomal degradation of multimeric NPC assemblies while sparing monomeric proteins, a selectivity profile attributed to the unique multimer-dependent activation mechanism of TRIM21. Beyond its activity as a molecular glue, (S)-ACE-OH has been utilized as a ligand to develop TRIM21-engaging PROTACs, offering a novel therapeutic platform for targeting pathologic protein aggregates, biomolecular condensates, and oncoproteins involved in cancer. The discovery of (S)-ACE-OH establishes TRIM21 as a viable E3 ligase for the selective elimination of diseased-associated protein complexes.

Other names
(S)-hydroxy-acepromazine(S)-1-(10-(3-(dimethylamino)propyl)-10H-phenothiazin-2-yl)ethanol(S)-2-(1-hydroxyethyl)promazine
02

Targets

NUP98TRIM21 (Tripartite motif-containing protein 21)

Beyond the preview

Go deeper on (S)-ACE-OH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-ACE-OH.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call